LACEY CAMPBELL: Open Payments
NPI 1093322240 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,939 in 143 payments from 24 companies in 2025. Trend: 2023 $1,399 · 2024 $1,886 · 2025 $6,939
Honoraria: $3,420Food & beverage: $2,829Travel & lodging: $690
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 18 | $4,628 |
| Dexcom, Inc. | 16 | $252 |
| Novo Nordisk Inc | 15 | $229 |
| RECORDATI_RARE_DISEASES_INC. | 10 | $221 |
| Xeris Pharmaceuticals, Inc. | 11 | $204 |
| SANOFI-AVENTIS U.S. LLC | 8 | $179 |
| Sequel Med Tech, LLC | 10 | $166 |
| Tandem Diabetes Care, Inc. | 8 | $164 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $111 |
| Lilly USA, LLC | 5 | $90 |
Products named: Korlym, Dexcom G6 Transmitter, ISTURISA, TZIELD, TWIIST, t:slim X2 Insulin Pump with Control-IQ, RECORLEV, JARDIANCE.
Industry payments across OK — which companies pay providers there.
